5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Persistent use of HIV prevention methods can be a challenge, particularly for some younger women. The long-acting, discreet, woman-centric dapivirine vaginal ring offers promise as a prevention method with less user burden, which could support continued use. We assessed dapivirine vaginal ring use to understand adherence patterns and identify characteristics influencing patterns.

          Related collections

          Author and article information

          Journal
          J Acquir Immune Defic Syndr
          Journal of acquired immune deficiency syndromes (1999)
          Ovid Technologies (Wolters Kluwer Health)
          1944-7884
          1525-4135
          Aug 01 2022
          : 90
          : 4
          Affiliations
          [1 ] Women's Global Health Imperative, RTI International, Berkeley, CA.
          [2 ] Fred Hutchinson Cancer Research Center, Seattle, WA.
          [3 ] Department of Biostatistics, University of Washington, Seattle, WA.
          [4 ] Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, Faculty of Health, Sciences, Johannesburg, South Africa.
          [5 ] Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA; and.
          [6 ] South African Medical Research Council, HPRU, Durban, South Africa.
          [7 ] CAPRISA, Durban, South Africa.
          [8 ] University of Pittsburgh, and Magee-Women's Research Institute, Pittsburgh, PA.
          [9 ] FHI 360, Durham, NC.
          [10 ] Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
          [11 ] Department of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, WA.
          [12 ] Current, Gilead Sciences, Foster City, CA.
          [13 ] Center for AIDS Prevention Studies, Department of Medicine, University of California, San Francisco, CA.
          [14 ] ASTRA consulting, Kensington, CA.
          Article
          NIHMS1792718 00126334-202208010-00008
          10.1097/QAI.0000000000002990
          9342948
          35344520
          c7034544-4ce6-4ddc-9d2d-5fb20fd2d8cb
          History

          Comments

          Comment on this article